Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors
Shi‐Yong Sun
Topics & Concepts
OsimertinibApoptosisEpidermal growth factor receptorLung cancerCancer researchCancerTyrosine kinaseProgrammed cell deathMedicineEpidermal growth factorBiologyReceptorOncologyInternal medicineErlotinibBiochemistryLung Cancer Treatments and MutationsCancer therapeutics and mechanismsPI3K/AKT/mTOR signaling in cancer